Pancreatic Cancer Research

ResearcherThe University of Kansas Cancer CenterNo recent work listed

Dharmalingam Subramaniam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2710-485X; OpenAlex author ID A5029226618. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper

Papers 8

  1. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Co-author DOI 10.1053/j.gastro.2019.11.279↗
  2. Super-enhancers: novel target for pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.26704↗
  3. Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer. Co-author DOI 10.2174/0929867324666170127095832↗
  4. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Last author DOI 10.18632/oncotarget.6560↗
  5. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. First author DOI 10.18632/oncotarget.4871↗
  6. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Co-author DOI 10.1158/1535-7163.mct-12-0102↗
  7. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Co-author DOI 10.1158/1535-7163.mct-11-0399↗
  8. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0016958↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shrikant Anant · 8 shared papers, 2011–2020 · strength 0.47
  2. Prasad R. Dandawate · 4 shared papers, 2016–2020 · strength 0.34
  3. Animesh Dhar · 5 shared papers, 2011–2020 · strength 0.30
  4. Chandrayee Ghosh · 2 shared papers, 2019–2020 · strength 0.18
  5. Subhash Padhyé · 3 shared papers, 2015–2020 · strength 0.17
  6. Weijing Sun · 1 shared paper, 2020 · strength 0.08
  7. Domenico Coppola · 1 shared paper, 2020 · strength 0.08
  8. Mokenge Peter Malafa · 1 shared paper, 2020 · strength 0.08
  9. Anup Kasi · 1 shared paper, 2020 · strength 0.08
  10. Sivapriya Ponnurangam · 2 shared papers, 2012–2016 · strength 0.08
  11. Danny R. Welch · 2 shared papers, 2011–2015 · strength 0.07
  12. Sitaram Harihar · 1 shared paper, 2015 · strength 0.04
  13. Parthasarathy Rangarajan · 1 shared paper, 2015 · strength 0.04
  14. Giridharan Periyasamy · 1 shared paper, 2012 · strength 0.03
  15. David C. Linehan · 1 shared paper, 2011 · strength 0.03
  16. Brian K. Dieckgraefe · 1 shared paper, 2011 · strength 0.03
  17. Courtney W. Houchen · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.